Bruce Andrews

Bruce Andrews is a longtime animal-health executive and private investor. LifeLearn’s board biography says he has worked in the animal health, pharmaceutical, and crop protection industries for more than three decades. He spent 20 years at American Cyanamid, ending as President of the Animal Health and Nutrition Division.

After American Cyanamid, Andrews was President of LifeLearn Inc. in 1995, according to Alpharma’s 2000 Form 10-K. He then worked as a consultant with Brakke Consulting from 1996 through May 1997 before joining Alpharma as Vice President and President of its Animal Health Division in May 1997. Alpharma’s filing listed him as age 54 in 2000.

Andrews later became Executive Vice President and President and CEO of Alpharma Animal Health, Inc.; LifeLearn’s board biography says he retired from Alpharma in 2001. Brakke Consulting also reported in 2001 that Carol Wrenn was named President of Alpharma’s Animal Health Division and that Andrews, the former division president, was retiring.

He has held multiple industry and board roles. LifeLearn states that he previously served on the boards of Agdata, Centaur Pharmaceuticals, and MariCal; chaired the International Federation for Animal Health; served as Vice Chairman of the Animal Health Institute; and served as President of the Animal Agricultural Alliance. He is currently listed by LifeLearn as Principal of 101 Investment Corporation, an investor in LifeLearn, and a LifeLearn board member since 1995.

• No public personal investment thesis or stated check-size range was found.
• His verified investing and board activity points to deep specialization in animal health and adjacent markets, especially companies serving veterinary practices, livestock, poultry, fish, pet health, animal nutrition, pharmaceutical feed additives, and animal-health data or software.
• LifeLearn describes itself as providing customizable online software solutions for veterinary practices and animal-health organizations, including education resources, marketing, communications, business-optimization tools, and AI-enabled products.
• His board history suggests he can add the most value where commercial strategy, animal-health industry distribution, regulatory context, and strategic partnerships matter.